[Methodological recommendations for surgical care in patients with hemophilia A receiving prophylactic therapy with emicizumab].

Autor: Andreeva TA; GBUZ 'City Polyclinic #37', City Hemophilia Treatment Center, St. Petersburg, Russian Federation, Zharkov PA; FGBU 'National Medical Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev', St. Petersburg, Russia, Zozulya NI; FGBU 'National Medical Research Center of Hematology', Ministry of Health of the Russian Federation, Moscow, Russian Federation, Zorenko VY; FGBU 'National Medical Research Center of Hematology', Ministry of Health of the Russian Federation, Moscow, Russian Federation, Konstantinova VN; GBUZ 'City Polyclinic #37', City Hemophilia Treatment Center, St. Petersburg, Russian Federation, Lavrentieva IN; GBUZ 'Morozov Children's City Clinical Hospital of the Moscow City Health Department', Moscow, Russian Federation, Davydkin IL; FGBOU VO 'Samara State Medical University', Ministry of Health of the Russian Federation, Samara, Russian Federation, Petrov VY; GBUZ 'Morozov Children's City Clinical Hospital of the Moscow City Health Department', Moscow, Russian Federation, Polyanskaya TY; FGBU 'National Medical Research Center of Hematology', Ministry of Health of the Russian Federation, Moscow, Russian Federation, Soldatenkov VE; FGBU 'Russian Research Institute of Hematology and Transfusiology FMBA', St. Petersburg, Russian Federation, Shutov SA; FGBU 'National Medical Research Center of Hematology', Ministry of Health of the Russian Federation, Moscow, Russian Federation

Publikováno v: Khirurgiia [Khirurgiia (Mosk)] 2024 (3. Vyp. 2), pp. 3-20.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.